WHO Pilots Faster Pre-Qualification Procedure For IVDs
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics are assessed by the World Health Organization to support use for priority diseases in low-resource regions. Under a new WHO process, performance evaluations for IVDs may be initiated at a much earlier stage than is currently allowed.
You may also be interested in...
WHO Plans New Fees For IVD Prequalification In Early 2018
A new fee structure for the prequalification of in vitro diagnostics by the World Health Organization is expected to come into effect in early 2018 following the introduction of a fee-for-service framework for medicines and vaccines in January 2017.
New WHO Prequalification Fees To Reap $20m A Year; Prices Could Rise As A Result
A new financing arrangement due to take effect in January 2017 will see manufacturers paying fees for the World Health Organization’s prequalification program in an effort to give it a firmer footing in the long term. While manufacturers have welcomed the new fee structure, the NGO Health Action International says safeguards will be needed to ensure regulation remains robust.
Japan Grants Global-First Approval To Zolbetuximab With 15 New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.